Particularly, the analysis of triple-negative breast cancer human samples showed the presence of PD-L1-low and PD-L1-high cells, with the latter characterized by the concomitant overexpression of stemness pathways, and by a higher spheroidogenic and tumorigenic potential in vitro and in vivo, respectively [201]. Here, CD274 is linked to triple-negative breast carcinoma.